Literature DB >> 32122997

Natural T Cell Epitope Containing Methyl Lysines on Mycobacterial Heparin-Binding Hemagglutinin.

Véronique Corbière1, Jérôme Segers2, Rémi Desmet2, Sophie Lecher2, Marc Loyens2, Emmanuelle Petit2, Oleg Melnyk2, Camille Locht2, Françoise Mascart3,4.   

Abstract

T cell epitopes are mostly nonmodified peptides, although posttranslationally modified peptide epitopes have been described, but they originated from viral or self-proteins. In this study, we provide evidence of a bacterial methylated T cell peptide epitope. The mycobacterial heparin-binding hemagglutinin (HBHA) is a protein Ag with a complex C-terminal methylation pattern and is recognized by T cells from humans latently infected with Mycobacterium tuberculosis By comparing native HBHA with recombinant HBHA produced in Mycobacterium smegmatis (rHBHA-Ms), we could link antigenic differences to differences in the methylation profile. Peptide scan analyses led to the discovery of a peptide containing methyl lysines recognized by a mAb that binds to native HBHA ∼100-fold better than to rHBHA-Ms This peptide was also recognized by T cells from latently infected humans, as evidenced by IFN-γ release upon peptide stimulation. The nonmethylated peptide did not induce IFN-γ, arguing that the methyl lysines are part of the T cell epitope.
Copyright © 2020 by The American Association of Immunologists, Inc.

Entities:  

Year:  2020        PMID: 32122997     DOI: 10.4049/jimmunol.1901214

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  2 in total

1.  Immuno-Diagnosis of Active Tuberculosis by a Combination of Cytokines/Chemokines Induced by Two Stage-Specific Mycobacterial Antigens: A Pilot Study in a Low TB Incidence Country.

Authors:  Violette Dirix; Philippe Collart; Anne Van Praet; Maya Hites; Nicolas Dauby; Sabine Allard; Judith Racapé; Mahavir Singh; Camille Locht; Françoise Mascart; Véronique Corbière
Journal:  Front Immunol       Date:  2022-03-10       Impact factor: 7.561

2.  Tuberculosis Risk Stratification of Psoriatic Patients Before Anti-TNF-α Treatment.

Authors:  Farida Benhadou; Violette Dirix; Fanny Domont; Fabienne Willaert; Anne Van Praet; Camille Locht; Françoise Mascart; Véronique Corbière
Journal:  Front Immunol       Date:  2021-06-03       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.